249 related articles for article (PubMed ID: 15494385)
1. Use of erythropoietin in heart failure management.
Caiola K; Cheng JW
Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of anemia in heart failure patients].
Santilli G; Tarantini L; Baio P; Senni M
G Ital Cardiol (Rome); 2011 May; 12(5):319-26. PubMed ID: 21593950
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents and heart failure.
Lipšic E; van der Meer P; van Veldhuisen DJ
Cardiovasc Ther; 2011 Aug; 29(4):e52-9. PubMed ID: 20973926
[TBL] [Abstract][Full Text] [Related]
5. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.
Crosato M; Steinborn W; Anker SD
Heart Fail Monit; 2003; 4(1):2-6. PubMed ID: 12808478
[TBL] [Abstract][Full Text] [Related]
6. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.
Lawler PR; Filion KB; Eisenberg MJ
J Card Fail; 2010 Aug; 16(8):649-58. PubMed ID: 20670844
[TBL] [Abstract][Full Text] [Related]
7. Optimizing anemia management in hospitalized patients with end-stage renal disease.
Heung M; Mueller BA; Segal JH
Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
[TBL] [Abstract][Full Text] [Related]
8. Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
McMurray JJ; Anand IS; Diaz R; Maggioni AP; O'Connor C; Pfeffer MA; Polu KR; Solomon SD; Sun Y; Swedberg K; Tendera M; van Veldhuisen DJ; Wasserman SM; Young JB;
Eur J Heart Fail; 2009 Aug; 11(8):795-801. PubMed ID: 19633103
[TBL] [Abstract][Full Text] [Related]
9. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
[TBL] [Abstract][Full Text] [Related]
10. Darbapoetin alfa does not help adults with heart failure and anaemia.
BMJ; 2013 Mar; 346():f1626. PubMed ID: 23487165
[No Abstract] [Full Text] [Related]
11. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
Coyne DW
Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and heart failure: the end of a promise?
Kleijn L; Westenbrink BD; van der Meer P
Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
[No Abstract] [Full Text] [Related]
13. Future directions in management of anemia in heart failure.
Agarwal AK; Katz SD
Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietic stimulating agents.
Testa U
Expert Opin Emerg Drugs; 2010 Mar; 15(1):119-38. PubMed ID: 20158404
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
Beck-da-Silva L; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
J Card Fail; 2007 Feb; 13(1):14-7. PubMed ID: 17338998
[TBL] [Abstract][Full Text] [Related]
17. Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?
Kleijn L; de Boer RA; Voors AA
Eur J Heart Fail; 2010 Mar; 12(3):215-6. PubMed ID: 20156936
[No Abstract] [Full Text] [Related]
18. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.
Howlett JG
Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):199-208. PubMed ID: 18248274
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.
van der Meer P; Groenveld HF; Januzzi JL; van Veldhuisen DJ
Heart; 2009 Aug; 95(16):1309-14. PubMed ID: 19168472
[TBL] [Abstract][Full Text] [Related]
20. Congestive heart failure-related anemia and a role for erythropoietin.
Akram K; Pearlman BL
Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
